Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
BMC Cancer|August 27, 2020
Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trialFarastuk Bozorgmehr, Inn Chung, Petros Christopoulos, et al.Molecular Biology of the Cell|February 13, 2009
Dynamics of telomeres and promyelocytic leukemia nuclear bodies in a telomerase-negative human cell lineThibaud Jegou, Inn Chung, Gerrit Heuvelman, et al.Clinical Lung Cancer|November 7, 2020
A Phase II Trial of Nivolumab With Chemotherapy Followed by Maintenance Nivolumab in Patients With Pleural Mesothelioma After Surgery: The NICITA Study ProtocolRajiv Shah, Laura V Klotz, Inn Chung, et al.BMC Cancer|June 29, 2021
Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping: study protocol of the ABP trialPetros Christopoulos, Farastuk Bozorgmehr, Lena Brückner, et al.Journal of Thoracic Disease|April 11, 2020
Paclitaxel for treatment of advanced small cell lung cancer (SCLC): a retrospective study of 185 patientsDamian von Eiff, Farastuk Bozorgmehr, Inn Chung, et al.Journal of Cell Science|February 5, 2010
Three-dimensional organization of promyelocytic leukemia nuclear bodiesMarion Lang, Thibaud Jegou, Inn Chung, et al.Methods (San Diego, Calif.)|October 12, 2016
Quantification of telomere features in tumor tissue sections by an automated 3D imaging-based workflowManuel Gunkel, Inn Chung, Stefan Wörz, et al.BMC Cancer|September 24, 2022
Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease - a randomized, open-label, multicenter phase II trialFarastuk Bozorgmehr, Petros Christopoulos, Inn Chung, et al.DNA Repair|May 1, 2016
SUMOylation of Rad52-Rad59 synergistically change the outcome of mitotic recombinationSonia Silva, Veronika Altmannova, Nadine Eckert-Boulet, et al.Frontiers in Oncology|April 26, 2021
<i>De Novo</i> Versus Secondary Metastatic <i>EGFR</i>-Mutated Non-Small-Cell Lung CancerFarastuk Bozorgmehr, Daniel Kazdal, Inn Chung, et al.Pageof 3